France’s Iliad is in exclusive talks on a deal to create a fourth Italian mobile telecoms operator that would smooth the way for CK Hutchison Holdings to merge its 3 Italia with Vimpelcom’s Wind, sources close to the matter said on Monday.
A fourth player would help Hutchison to gain antitrust approval for a merger that would leave Telecom Italia and Vodafone Italia as the only other mobile network competitors in Italy.
Hutchison had offered frequencies and infrastructure assets to Iliad in competition with Swisscom’s Italian broadband business Fastweb, but Iliad is now in pole position, the sources said.
It is the third attempt by billionaire Xavier Niel, majority owner of Iliad, to expand his activities outside France, where he is known for having triggered a price war in 2012 with Free Mobile’s low-cost services.
Niel first tried to get a foothold in the United States with an ultimately unsuccesful bid for Deutsche Telekom’s T-Mobile unit in 2014. He also considered a move into the British market this year.
The European Commission will have the final say on whether Iliad can compete effectively with the existing network operators.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas